AmBisone: an international workshop. Australia. July 8-9, 2000.
D000666:Amphotericin B / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy*
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B